Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia highlight some of the regulatory challenges for drug-device combination products in APAC, including the lack…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations housed under their umbrella and looks towards the biggest challenges healthcare is…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of…
Dentons Germany’s Peter Homberg outlines the key requirements that companies need to fulfil in order to…
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia…
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
I recently had the pleasure to moderate an event on the COVID-19 impact on the relationship between Doctor and…